Lenalidomide-Related Spinal Cord Infarction in Primary Amyloidosis

Chen Makranz, Boaz Nachmias, Moshe Gatt, Ruth Eliahou, Alexander Lossos

Research output: Contribution to journalArticlepeer-review


Spinal cord infarction is a rare but often devastating disorder caused by disruption in the vascular spinal supply. We report a patient with spinal cord infarction associated with lenalidomide therapy for primary amyloidosis, in the background of other predisposing factors. We describe the clinical case and discuss the possible explanation for this rare complication. As spinal cord infarction is not a known complication of lenalidomide therapy or amyloidosis, this description raises the potential of such a side effect in some certain conditions and discusses the role of the old and new anticoagulant agents in prevention of thromboembolic complications in high-risk patients.
Original languageAmerican English
Pages (from-to)124-128
Number of pages5
JournalArchives of Clinical and Medical Case Reports
Issue number4
StatePublished - 1 Jan 2018


Dive into the research topics of 'Lenalidomide-Related Spinal Cord Infarction in Primary Amyloidosis'. Together they form a unique fingerprint.

Cite this